Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-ketamine for Sedation During Bronchoscopy
NCT01158820Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine in sedation, sponsored by University of Pennsylvania. Primary endpoint: Decreased Minute Ventilation at 58.5 minutes. Started Jun 2010; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT01158820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158820.